secwatch.observer — SEC 8-K summary
======================================

Issuer:     Design Therapeutics, Inc. (DSGN)
CIK:        0001807120
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001193125-26-031772
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Design Therapeutics board member Deepa Prasad resigns effective Feb 1, 2026
---------------------------------------------------------------------------

- Deepa Prasad resigned from Design Therapeutics Board of Directors effective February 1, 2026.
- Resignation due to conflict-avoidance policies associated with her new role at a major bank.
- No replacement or other board changes announced; remaining directors continue in office.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1807120/000119312526031772/0001193125-26-031772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1807120/000119312526031772/d14213d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-031772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer